UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000005745
Receipt number R000005821
Scientific Title The effect of continuous Intra-articurar infusion of Ropivacaine on postoperative pain following shoulder
Date of disclosure of the study information 2011/06/09
Last modified on 2015/06/08 12:20:27

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

The effect of continuous Intra-articurar infusion of Ropivacaine on postoperative pain following shoulder

Acronym

The effect of continuous Intra-articurar infusion of Ropivacaine on postoperative pain following shoulder

Scientific Title

The effect of continuous Intra-articurar infusion of Ropivacaine on postoperative pain following shoulder

Scientific Title:Acronym

The effect of continuous Intra-articurar infusion of Ropivacaine on postoperative pain following shoulder

Region

Japan


Condition

Condition

Patients required shoulder arthroscopic surgery

Classification by specialty

Orthopedics Anesthesiology Adult

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

The purpouse of this study is to determine the analgestic efficacy of subacrominal infusion of ropivacaine after shoulder arthroscopic surgery

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1

Confirmatory

Trial characteristics_2

Pragmatic

Developmental phase

Not applicable


Assessment

Primary outcomes

numerical rating scale

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Active

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

4

Purpose of intervention

Treatment

Type of intervention

Medicine

Interventions/Control_1

All patients are scheduled to receive an inter scalene brachial plexus block.
0.2%ropivacaine at 2ml/h via infusion pump into the sub acromal space.
Pain is evaluated using numerical rating scale (NRS) until 24 houres after surgery.

Interventions/Control_2

All patients are scheduled to receive an inter scalene brachial plexus block.
0.2%ropivacaine at 4ml/h via infusion pump into the sub acromal space.

Interventions/Control_3

All patients are scheduled to receive an inter scalene brachial plexus block.
0.2%ropivacaine at 8ml/h via infusion pump into the sub acromal space.

Interventions/Control_4

Patients receive an inter scalene brachial plexus block only

Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

75 years-old >=

Gender

Male and Female

Key inclusion criteria

Patients undergoing arthroscopic rotator cuff repair

Key exclusion criteria

hepatic dysfunction
renal dysfunction
obesity
reoperation
medicine allergy
ASA physical status >=3

Target sample size

40


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Yumiko Kohno

Organization

HigashiOmiya General hospital

Division name

Anestesiology

Zip code


Address

5-18 HigasiOmiya,minuma-ku,Saitama-City,Japan

TEL

0486847111

Email

ykohno-ymi@umin.ac.jp


Public contact

Name of contact person

1st name
Middle name
Last name Yumiko Kohno

Organization

HigashiOmiya General hospital

Division name

Anestesiology

Zip code


Address

5-18.HigasiOmiya,minuma-ku,Saitama-City,Japan

TEL

0486847111

Homepage URL


Email

ykohno-ymi@umin.ac.jp


Sponsor or person

Institute

HigashiOmiya General hospital

Institute

Department

Personal name



Funding Source

Organization

HigashiOmiya General hospital

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization

Japan


Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

東大宮総合病院(埼玉県)


Other administrative information

Date of disclosure of the study information

2011 Year 06 Month 09 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Suspended

Date of protocol fixation

2011 Year 01 Month 20 Day

Date of IRB


Anticipated trial start date

2011 Year 02 Month 01 Day

Last follow-up date


Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2011 Year 06 Month 08 Day

Last modified on

2015 Year 06 Month 08 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000005821


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name